Danny Wiederkehr MPH

Danny Wiederkehr is the Global Lead for the Health Economics and Outcomes Research (HEOR) Team supporting cardiovascular medicine at Pfizer. Danny believes we have only slightly tapped the potential of real-world evidence to drive better decision making in healthcare, improve the efficiency of care delivery and improve patient outcomes. With Pfizer for 9 years, he has held several roles across Medical Affairs, Global Policy, and Real World Data and Analytics, developing a deep appreciation for the intersection of clinical expertise, policy knowledge, analytic tools that are driving innovation in real-world evidence generation.

Prior to joining Pfizer, Danny led several life science consulting teams and has published over 80 analyses using healthcare claims databases, electronic health records, and national health surveys. He holds an undergraduate degree in Mathematics and Gender Studies from the University of Notre Dame and a Masters of Public Health in Health Policy and Management from Columbia University.